[ad_1]
Good news from Brussels. The European Union could give the green light to the sale of Pfizer and Moderna vaccines in the second half of December. He says it European Commission President Ursula von der Leyen says it all depends on the results of the European Medicines Agency’s evaluation of the twoCOVID.
The head of the European Commission recalls that the Union has clashed with 5 producers ofCOVID. The advantage is that the sera use 4 different technologies which could be effective for various segments of the population.
“The EMA (European Medicines Agency) is in daily contact with the FDA (similar body in the United States) to synchronize the evaluation of the vaccines and if all goes smoothly, the EMA says that the authorization could be granted in trade for Biontech and Moderna vaccines in the second half of December 2020“, A spus Von der Leyen.
“We have adopted 5 contracts with BionTech, CureVac, Astra / Zeneca, Johnson & Johnson and Sanofi. We are continuing negotiations with Moderna and are in talks with Novavax. It was gratifying to see that all Member States agreed to buy these vaccines and remain in our portfolio. This portfolio of 5 vaccines, hopefully 6 soon, is important because it covers four different manufacturing technologies. Some vaccines may work better in some parts of the population than othersShe added.
Publisher: Monica Bonea
.
[ad_2]
Source link
